{"id":"https://openalex.org/W2102675827","doi":"https://doi.org/10.2337/diacare.28.7.1547","title":"A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia","display_name":"A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W2102675827","doi":"https://doi.org/10.2337/diacare.28.7.1547","mag":"2102675827","pmid":"https://pubmed.ncbi.nlm.nih.gov/15983299"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.28.7.1547","doi":"https://doi.org/10.2337/diacare.28.7.1547","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.28.7.1547","pdf_url":"https://diabetesjournals.org/care/article-pdf/28/7/1547/568216/zdc00705001547.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://diabetesjournals.org/care/article-pdf/28/7/1547/568216/zdc00705001547.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011389314","display_name":"Ronald B Goldberg","orcid":"https://orcid.org/0000-0003-0924-1110","observed_orcids":["https://orcid.org/0000-0003-0924-1110"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald B. Goldberg","raw_affiliation_strings":["Division of Endocrinology, Metabolism, and Diabetes, University of Miami School of Medicine, Miami, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Metabolism, and Diabetes, University of Miami School of Medicine, Miami, Florida","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013350892","display_name":"David M. Kendall","orcid":"https://orcid.org/0000-0003-1910-2587","observed_orcids":["https://orcid.org/0000-0003-1910-2587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Kendall","raw_affiliation_strings":["International Diabetes Center, Park Nicollet Institute, Minneapolis, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Diabetes Center, Park Nicollet Institute, Minneapolis, Minnesota","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057449551","display_name":"Mark A. Deeg","orcid":"https://orcid.org/0000-0001-6920-9396","observed_orcids":["https://orcid.org/0000-0001-6920-9396"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Deeg","raw_affiliation_strings":["Division of Endocrinology and Metabolism, Department of Veterans Affairs and the Indiana University School of Medicine, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Metabolism, Department of Veterans Affairs and the Indiana University School of Medicine, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876","https://orcid.org/0000-0001-6894-4110"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John B. Buse","raw_affiliation_strings":["Divisions of Endocrinology and of General Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Endocrinology and of General Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012043091","display_name":"Anthony J. Zagar","orcid":"https://orcid.org/0000-0002-8353-6665","observed_orcids":["https://orcid.org/0000-0002-8353-6665"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony J. Zagar","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018937404","display_name":"Jane A. Pinaire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane A. Pinaire","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016547950","display_name":"Meng Hee Tan","orcid":"https://orcid.org/0000-0001-6674-2611","observed_orcids":["https://orcid.org/0000-0001-6674-2611"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meng H. Tan","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103944459","display_name":"Mehmood A. Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmood A. Khan","raw_affiliation_strings":["Takeda Pharmaceuticals North America, Lincolnshire, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals North America, Lincolnshire, Illinois","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103745313","display_name":"Alfonso T. Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alfonso T. Perez","raw_affiliation_strings":["Takeda Global Research and Development Center, Lincolnshire, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, Lincolnshire, Illinois","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110236818","display_name":"Scott J. Jacober","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J. Jacober","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the GLAI Study Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the GLAI Study Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":50.4673,"has_fulltext":true,"cited_by_count":793,"citation_normalized_percentile":{"value":0.9992935,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"28","issue":"7","first_page":"1547","last_page":"1554"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.02250000089406967,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.019899999722838402,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.890999972820282},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9110000133514404},{"id":"https://openalex.org/keywords/plasma-lipids","display_name":"plasma lipids","score":0.8029999732971191},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9900000095367432},{"id":"https://openalex.org/keywords/ldl-particle-size","display_name":"LDL particle size","score":0.9100000262260437},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9480000138282776},{"id":"https://openalex.org/keywords/drug-comparison","display_name":"drug comparison","score":0.5460000038146973},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6190000176429749},{"id":"https://openalex.org/keywords/oral-antidiabetic-therapy","display_name":"oral antidiabetic therapy","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9891839027404785},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.9687790274620056},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8631608486175537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7612260580062866},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.7108929753303528},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6693023443222046},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.620337724685669},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5531967282295227},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5529572367668152},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4682365953922272},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.42630085349082947},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3608107566833496},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2337/diacare.28.7.1547","doi":"https://doi.org/10.2337/diacare.28.7.1547","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.28.7.1547","pdf_url":"https://diabetesjournals.org/care/article-pdf/28/7/1547/568216/zdc00705001547.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:15983299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15983299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.602.6239","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.602.6239","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/28/7/1547.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/diacare.28.7.1547","doi":"https://doi.org/10.2337/diacare.28.7.1547","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.28.7.1547","pdf_url":"https://diabetesjournals.org/care/article-pdf/28/7/1547/568216/zdc00705001547.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320308576","display_name":"Takeda Pharmaceuticals North America","ror":"https://ror.org/03bygaq51"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2102675827.pdf","grobid_xml":"https://content.openalex.org/works/W2102675827.grobid-xml"},"referenced_works_count":66,"referenced_works":["https://openalex.org/W43054701","https://openalex.org/W131572430","https://openalex.org/W1494628690","https://openalex.org/W1547380883","https://openalex.org/W1554313394","https://openalex.org/W1565183637","https://openalex.org/W1851490742","https://openalex.org/W1963775513","https://openalex.org/W1963886325","https://openalex.org/W1969102243","https://openalex.org/W1969377903","https://openalex.org/W1974805788","https://openalex.org/W1977386411","https://openalex.org/W1977435928","https://openalex.org/W1981075911","https://openalex.org/W1982990554","https://openalex.org/W1986229866","https://openalex.org/W1989674865","https://openalex.org/W1989719065","https://openalex.org/W2015279471","https://openalex.org/W2017421207","https://openalex.org/W2020984463","https://openalex.org/W2021976026","https://openalex.org/W2026462386","https://openalex.org/W2037447341","https://openalex.org/W2037694536","https://openalex.org/W2039401819","https://openalex.org/W2045570675","https://openalex.org/W2049412794","https://openalex.org/W2049571309","https://openalex.org/W2053365438","https://openalex.org/W2054404971","https://openalex.org/W2056726092","https://openalex.org/W2063641411","https://openalex.org/W2077760013","https://openalex.org/W2077843346","https://openalex.org/W2077997765","https://openalex.org/W2079614274","https://openalex.org/W2080846100","https://openalex.org/W2083419076","https://openalex.org/W2089907280","https://openalex.org/W2093894290","https://openalex.org/W2100233089","https://openalex.org/W2100927239","https://openalex.org/W2102605421","https://openalex.org/W2105362864","https://openalex.org/W2106343349","https://openalex.org/W2107287443","https://openalex.org/W2107298817","https://openalex.org/W2109934064","https://openalex.org/W2110641080","https://openalex.org/W2114002328","https://openalex.org/W2124186024","https://openalex.org/W2127307547","https://openalex.org/W2129563195","https://openalex.org/W2131669718","https://openalex.org/W2155598961","https://openalex.org/W2160234571","https://openalex.org/W2328529137","https://openalex.org/W2411329118","https://openalex.org/W2413957904","https://openalex.org/W4238251256","https://openalex.org/W4244771114","https://openalex.org/W4246764494","https://openalex.org/W4248522613","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W7100501794","https://openalex.org/W1963886325","https://openalex.org/W2109934064","https://openalex.org/W2117205405","https://openalex.org/W2018037013","https://openalex.org/W2183844286","https://openalex.org/W2120086542","https://openalex.org/W2072664557","https://openalex.org/W2354249222","https://openalex.org/W2131215476"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Published":[1],"reports":[2],"suggest":[3],"that":[4],"pioglitazone":[5,49,92,210,221,235],"and":[6,37,45,50,73,190,222,241,277],"rosiglitazone":[7,123,165,225,242,264],"have":[8,243],"different":[9,245],"effects":[10,47,246],"on":[11,247],"lipids":[12,249],"in":[13,174,193,270],"patients":[14],"with":[15,59,67,77,99,129,154,164,212,220,224,234,263,267],"type":[16,63],"2":[17,64],"diabetes.":[18],"However,":[19],"these":[20],"previous":[21],"studies":[22],"were":[23,97,127,147,157],"either":[24],"retrospective":[25],"chart":[26],"reviews":[27],"or":[28,70,254,257],"clinical":[29],"trials":[30],"not":[31],"rigorously":[32],"controlled":[33],"for":[34,104,113,140,209],"concomitant":[35,255],"glucose-":[36],"lipid-lowering":[38,79,256],"therapies.":[39],"This":[40],"study":[41],"examines":[42],"the":[43,91,141,172,191],"lipid":[44],"glycemic":[46,252],"of":[48,62,251],"rosiglitazone.":[51],"RESEARCH":[52],"DESIGN":[53],"AND":[54],"METHODS:":[55],"We":[56],"enrolled":[57],"subjects":[58,87,119],"a":[60,82],"diagnosis":[61],"diabetes":[65],"(treated":[66],"diet":[68],"alone":[69],"oral":[71],"monotherapy)":[72],"dyslipidemia":[74],"(not":[75],"treated":[76,98,128],"any":[78],"agents).":[80],"After":[81],"4-week":[83],"placebo":[84],"washout":[85],"period,":[86],"randomly":[88,120],"assigned":[89,121],"to":[90,122],"arm":[93],"(n":[94,124],"=":[95,125,237],"400)":[96],"30":[100],"mg":[101,110,131,137],"once":[102,111,132],"daily":[103,112,133,139],"12":[105,116],"weeks":[106],"followed":[107,134],"by":[108,135,149,159],"45":[109],"an":[114],"additional":[115],"weeks,":[117],"whereas":[118],"402)":[126],"4":[130,136],"twice":[138],"same":[142],"intervals.":[143],"RESULTS:":[144],"Triglyceride":[145],"levels":[146],"reduced":[148,219],"51.9":[150],"+/-":[151,161,180,184,199,203],"7.8":[152,162],"mg/dl":[153,163],"pioglitazone,":[155],"but":[156],"increased":[158,223,232],"13.1":[160],"(P":[166,226,236],"<":[167,188,207,227],"0.001":[168],"between":[169],"treatments).":[170],"Additionally,":[171],"increase":[173,192],"HDL":[175,272],"cholesterol":[176,195],"was":[177,196,218],"greater":[178],"(5.2":[179],"0.5":[181,185],"vs.":[182,201],"2.4":[183],"mg/dl;":[186,205],"P":[187,206],"0.001)":[189,208],"LDL":[194,215,229,274,278],"less":[197],"(12.3":[198],"1.6":[200,204],"21.3":[202],"compared":[211,262],"rosiglitazone,":[213],"respectively.":[214],"particle":[216,230,275,279],"concentration":[217],"0.001).":[228],"size":[231],"more":[233],"0.005).":[238],"CONCLUSIONS:":[239],"Pioglitazone":[240,261],"significantly":[244],"plasma":[248],"independent":[250],"control":[253],"other":[258],"antihyperglycemic":[259],"therapy.":[260],"is":[265],"associated":[266],"significant":[268],"improvements":[269],"triglycerides,":[271],"cholesterol,":[273],"concentration,":[276],"size.":[280]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":23},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":41},{"year":2012,"cited_by_count":46}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}